ARTICLE | Financial News
Invirsa raises $520K in seed round
November 10, 2017 8:46 PM UTC
Infectious disease play Invirsa Inc. (Columbus, Ohio) raised $520,000 in a seed financing led by CincyTech. Initial investor Rev1 Ventures also participated.
Invirsa's lead candidate, INV-102, is in preclinical testing to treat acute conjunctivitis and upper respiratory tract infections. The therapy is a derivative of an undisclosed naturally occurring small molecule...